The newer antibiotics: some therapeutic considerations.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D002228:Carbenicillin / Q000627:therapeutic use; D002506:Cephalexin / Q000627:therapeutic use; D002507:Cephaloglycin / Q000627:therapeutic use; D002511:Cephalosporins; D004756:Enterobacteriaceae Infections / Q000188:drug therapy; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D011552:Pseudomonas Infections / Q000188:drug therapy; D012293:Rifampin / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D005839:Gentamicins; D002228:Carbenicillin; D002507:Cephaloglycin; D002506:Cephalexin; D012293:Rifampin